Publication | Closed Access
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)
95
Citations
34
References
2007
Year
Tumor BiologyOncologyMedicineCancer BiologyAnti-cancer AgentTumor SuppressorCancer TreatmentPharmacologyCell BiologyMultidrug-resistant Cancer CellsCancer ResearchPreferential Targets
| Year | Citations | |
|---|---|---|
Page 1
Page 1